NMOSD-话题@MedSci

#NMOSD#

11篇内容 | 1458人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2228985, encodeId=1e4a2228985fa, content=<a href='/topic/show?id=581e26889ea' target=_blank style='color:#2F92EE;'>#依库珠单抗#</a> <a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Neurology：依库珠单抗在神经脊髓炎谱系障碍中的应用, objectType=article, longId=845693, objectId=9b7784569329, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301015/1697393510287_4754896.jpeg, objectUrl=/article/show_article.do?id=9b7784569329, replyNumber=0, likeNumber=69, createdTime=2024-10-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=9b7784569329, moduleTitle=Neurology：依库珠单抗在神经脊髓炎谱系障碍中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b7784569329)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199681, encodeId=fd4a2199681e0, content=<a href='/topic/show?id=bf0f1030431a' target=_blank style='color:#2F92EE;'>#麻醉#</a> <a href='/topic/show?id=abcd90e22c3' target=_blank style='color:#2F92EE;'>#视神经脊髓炎#</a> <a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=探究病因讲麻醉—视神经脊髓炎患者的麻醉选择, objectType=article, longId=822153, objectId=fa6f82215384, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/group-of-surgeons-in-operating-room-at-hospital-PBS9LGH.jpg, objectUrl=/article/show_article.do?id=fa6f82215384, replyNumber=0, likeNumber=92, createdTime=2024-04-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=fa6f82215384, moduleTitle=探究病因讲麻醉—视神经脊髓炎患者的麻醉选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa6f82215384)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190743, encodeId=fc0c2190e43c2, content=<a href='/topic/show?id=abcd90e22c3' target=_blank style='color:#2F92EE;'>#视神经脊髓炎#</a> <a href='/topic/show?id=798d93652e6' target=_blank style='color:#2F92EE;'>#载脂蛋白E#</a> <a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Science子刊：首都医科大学施福东/金薇娜揭示新机制，或可为治疗视神经脊髓炎神经损伤提供新策略, objectType=article, longId=815590, objectId=1df2815590f0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=1df2815590f0, replyNumber=0, likeNumber=93, createdTime=2024-03-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1df2815590f0, moduleTitle=Science子刊：首都医科大学施福东/金薇娜揭示新机制，或可为治疗视神经脊髓炎神经损伤提供新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1df2815590f0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1539039, encodeId=80881539039ea, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=NMPA批准Uplizna(伊奈利珠单抗)治疗视神经脊髓炎谱系疾病(NMOSD), objectType=article, longId=300728, objectId=859d300e2836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=859d300e2836, replyNumber=0, likeNumber=101, createdTime=2022-03-16, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=859d300e2836, moduleTitle=NMPA批准Uplizna(伊奈利珠单抗)治疗视神经脊髓炎谱系疾病(NMOSD), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=859d300e2836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539038, encodeId=3e6c15390383d, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=JNNP：MOG抗体疾病的脑结构改变：与AQP4血清阳性NMOSD和MS的比较研究, objectType=article, longId=208606, objectId=ea8220860648, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea8220860648, replyNumber=0, likeNumber=92, createdTime=2021-03-19, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea8220860648, moduleTitle=JNNP：MOG抗体疾病的脑结构改变：与AQP4血清阳性NMOSD和MS的比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea8220860648)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539037, encodeId=e96a153903eba, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=2020EAN大会速递丨Satralizumab在NMOSD患者中的PK/PD特征支持其给药方案, objectType=article, longId=195607, objectId=c7a119560ea0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7a119560ea0, replyNumber=0, likeNumber=76, createdTime=2020-06-12, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7a119560ea0, moduleTitle=2020EAN大会速递丨Satralizumab在NMOSD患者中的PK/PD特征支持其给药方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7a119560ea0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539036, encodeId=3441153903650, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=2020EAN大会速递丨青少年NMOSD患者Satralizumab给药方案：与成年患者一致, objectType=article, longId=195606, objectId=b86a1956069e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b86a1956069e, replyNumber=0, likeNumber=0, createdTime=2020-06-12, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b86a1956069e, moduleTitle=2020EAN大会速递丨青少年NMOSD患者Satralizumab给药方案：与成年患者一致, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b86a1956069e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539035, encodeId=caea153903518, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Lancet Neurology：Satralizumab治疗视神经脊髓炎谱系障碍（NMOSD），安全有效, objectType=article, longId=193031, objectId=f1fd19303162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1fd19303162, replyNumber=0, likeNumber=65, createdTime=2020-04-28, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1fd19303162, moduleTitle=Lancet Neurology：Satralizumab治疗视神经脊髓炎谱系障碍（NMOSD），安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1fd19303162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539034, encodeId=751a1539034f3, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险, objectType=article, longId=179047, objectId=b78a1e90479f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b78a1e90479f, replyNumber=0, likeNumber=75, createdTime=2019-09-08, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b78a1e90479f, moduleTitle=Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b78a1e90479f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539033, encodeId=00e91539033e4, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Neurology：血清GFAP和神经丝作为NMOSD患者疾病活动和残疾的生物标志, objectType=article, longId=178527, objectId=d55a1e85277c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d55a1e85277c, replyNumber=0, likeNumber=73, createdTime=2019-09-03, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d55a1e85277c, moduleTitle=Neurology：血清GFAP和神经丝作为NMOSD患者疾病活动和残疾的生物标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d55a1e85277c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539032, encodeId=a47e153903253, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=NEJM：Eculizumab治疗可降低AQP4-IgG阳性的NMOSD患者复发风险, objectType=article, longId=177729, objectId=e7ca1e77290c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7ca1e77290c, replyNumber=0, likeNumber=80, createdTime=2019-08-17, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7ca1e77290c, moduleTitle=NEJM：Eculizumab治疗可降低AQP4-IgG阳性的NMOSD患者复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7ca1e77290c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539031, encodeId=bd9b1539031ae, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=FDA将优先审查C5补体单抗Eculizumab用于治疗视神经脊髓炎NMOSD患者, objectType=article, longId=160990, objectId=a84816099051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a84816099051, replyNumber=0, likeNumber=63, createdTime=2019-02-26, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a84816099051, moduleTitle=FDA将优先审查C5补体单抗Eculizumab用于治疗视神经脊髓炎NMOSD患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a84816099051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539030, encodeId=30ca1539030d7, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Neurology：神经脊髓炎谱系障碍（NMOSD）增加了女性流产的风险, objectType=article, longId=61648, objectId=f3676164831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3676164831, replyNumber=0, likeNumber=61, createdTime=2016-01-06, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3676164831, moduleTitle=Neurology：神经脊髓炎谱系障碍（NMOSD）增加了女性流产的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3676164831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539029, encodeId=cf4c153902917, content=<a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Mult Scler：妊娠导致 NMOSD发作的危险因素, objectType=article, longId=50862, objectId=ed7750862bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed7750862bf, replyNumber=0, likeNumber=70, createdTime=2015-05-18, rootId=0, userName=AspirantSuo, userId=7e1f13099713, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed7750862bf, moduleTitle=Mult Scler：妊娠导致 NMOSD发作的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed7750862bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NMOSD

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#依库珠单抗# #NMOSD#

Neurology：依库珠单抗在神经脊髓炎谱系障碍中的应用

2024-10-03发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#麻醉# #视神经脊髓炎# #NMOSD#

探究病因讲麻醉—视神经脊髓炎患者的麻醉选择

2024-04-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#视神经脊髓炎# #载脂蛋白E# #NMOSD#

Science子刊：首都医科大学施福东/金薇娜揭示新机制，或可为治疗视神经脊髓炎神经损伤提供新策略

2024-03-03发表于上海

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

NMPA批准Uplizna(伊奈利珠单抗)治疗视神经脊髓炎谱系疾病(NMOSD)

2022-03-16

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

JNNP：MOG抗体疾病的脑结构改变：与AQP4血清阳性NMOSD和MS的比较研究

2021-03-19

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

2020EAN大会速递丨Satralizumab在NMOSD患者中的PK/PD特征支持其给药方案

2020-06-12

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

2020EAN大会速递丨青少年NMOSD患者Satralizumab给药方案：与成年患者一致

2020-06-12

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

Lancet Neurology：Satralizumab治疗视神经脊髓炎谱系障碍（NMOSD），安全有效

2020-04-28

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险

2019-09-08

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

Neurology：血清GFAP和神经丝作为NMOSD患者疾病活动和残疾的生物标志

2019-09-03

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

NEJM：Eculizumab治疗可降低AQP4-IgG阳性的NMOSD患者复发风险

2019-08-17

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

FDA将优先审查C5补体单抗Eculizumab用于治疗视神经脊髓炎NMOSD患者

2019-02-26

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

Neurology：神经脊髓炎谱系障碍（NMOSD）增加了女性流产的风险

2016-01-06

AspirantSuo (审核中...)

前往app查看评论内容

#NMOSD#

Mult Scler：妊娠导致 NMOSD发作的危险因素

2015-05-18

科室
- - 订阅+
  - 更多科室
工具
服务